ENTX
NASD Entera Bio Ltd.$2.50 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.50, $0.02 below the day’s high of $2.52
- YTD change
- +28.87%
- vs 20-day SMA
- -11.12%
- vs 200-day SMA
- +38.07%
Price ranges
Price & Performance
+1.33 (+113.68%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 75.4% away from all-time highs of $10.16
- ENTX is up 29% since the beginning of the year
- ENTX is up 15% over the past 12 months
- ENTX is down 12% over the past 1 month
- 1% of all ENTX investors are betting against ENTX
ENTX reads not so good: price sits above one of the two key moving averages, the 12-month move is +15.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -14.09%
- vs 8-day SMA
- -7.83%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.